593 related articles for article (PubMed ID: 9107093)
1. Factor V and protein S as cofactors to activated protein C.
Dahlbäck B
Haematologica; 1997; 82(1):91-5. PubMed ID: 9107093
[TBL] [Abstract][Full Text] [Related]
2. Synergistic cofactor function of factor V and protein S to activated protein C in the inactivation of the factor VIIIa - factor IXa complex -- species specific interactions of components of the protein C anticoagulant system.
Shen L; He X; Dahlbäck B
Thromb Haemost; 1997 Sep; 78(3):1030-6. PubMed ID: 9308749
[TBL] [Abstract][Full Text] [Related]
3. Resistance to activated protein C as risk factor for thrombosis: molecular mechanisms, laboratory investigation, and clinical management.
Dahlbäck B
Semin Hematol; 1997 Jul; 34(3):217-34. PubMed ID: 9241707
[TBL] [Abstract][Full Text] [Related]
4. Factor V enhances the cofactor function of protein S in the APC-mediated inactivation of factor VIII: influence of the factor VR506Q mutation.
Váradi K; Rosing J; Tans G; Pabinger I; Keil B; Schwarz HP
Thromb Haemost; 1996 Aug; 76(2):208-14. PubMed ID: 8865533
[TBL] [Abstract][Full Text] [Related]
5. C4b-binding protein inhibits the factor V-dependent but not the factor V-independent cofactor activity of protein S in the activated protein C-mediated inactivation of factor VIIIa.
van de Poel RH; Meijers JC; Bouma BN
Thromb Haemost; 2001 May; 85(5):761-5. PubMed ID: 11372664
[TBL] [Abstract][Full Text] [Related]
6. Resistance to activated protein C caused by the R506Q mutation in the gene for factor V is a common risk factor for venous thrombosis.
Dahlbck B
J Intern Med Suppl; 1997; 740():1-8. PubMed ID: 9350175
[TBL] [Abstract][Full Text] [Related]
7. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.
Camire RM; Kalafatis M; Tracy PB
Biochemistry; 1998 Aug; 37(34):11896-906. PubMed ID: 9718313
[TBL] [Abstract][Full Text] [Related]
8. Coagulation factor V: an old star shines again.
Rosing J; Tans G
Thromb Haemost; 1997 Jul; 78(1):427-33. PubMed ID: 9198191
[TBL] [Abstract][Full Text] [Related]
9. The anticoagulant protein C pathway.
Dahlbäck B; Villoutreix BO
FEBS Lett; 2005 Jun; 579(15):3310-6. PubMed ID: 15943976
[TBL] [Abstract][Full Text] [Related]
10. Protein S down-regulates factor Xase activity independent of activated protein C: specific binding of factor VIII(a) to protein S inhibits interactions with factor IXa.
Takeyama M; Nogami K; Saenko EL; Soeda T; Nishiya K; Ogiwara K; Yoshioka A; Shima M
Br J Haematol; 2008 Nov; 143(3):409-20. PubMed ID: 18759761
[TBL] [Abstract][Full Text] [Related]
11. Activated protein C resistance and thrombosis: molecular mechanisms of hypercoagulable state due to FVR506Q mutation.
Dahlbäck B
Semin Thromb Hemost; 1999; 25(3):273-89. PubMed ID: 10443959
[TBL] [Abstract][Full Text] [Related]
12. Regulation of thrombin formation by activated protein C: effect of the factor V Leiden mutation.
Tans G; Nicolaes GA; Rosing J
Semin Hematol; 1997 Jul; 34(3):244-55. PubMed ID: 9241709
[TBL] [Abstract][Full Text] [Related]
13. Regulation of blood coagulation by the protein C anticoagulant pathway: novel insights into structure-function relationships and molecular recognition.
Dahlbäck B; Villoutreix BO
Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1311-20. PubMed ID: 15860736
[TBL] [Abstract][Full Text] [Related]
14. New molecular insights into the genetics of thrombophilia. Resistance to activated protein C caused by Arg506 to Gln mutation in factor V as a pathogenic risk factor for venous thrombosis.
Dahlbäck B
Thromb Haemost; 1995 Jul; 74(1):139-48. PubMed ID: 8578447
[TBL] [Abstract][Full Text] [Related]
15. Protein S and C4b-binding protein: components involved in the regulation of the protein C anticoagulant system.
Dahlbäck B
Thromb Haemost; 1991 Jul; 66(1):49-61. PubMed ID: 1833851
[TBL] [Abstract][Full Text] [Related]
16. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
Lämmle B; Griffin JH
Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
[TBL] [Abstract][Full Text] [Related]
17. Congenital and acquired activated protein C resistance.
Nicolaes GA; Dahlbäck B
Semin Vasc Med; 2003 Feb; 3(1):33-46. PubMed ID: 15199491
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of human factor VIII by activated protein C. Cofactor activity of protein S and protective effect of von Willebrand factor.
Koedam JA; Meijers JC; Sixma JJ; Bouma BN
J Clin Invest; 1988 Oct; 82(4):1236-43. PubMed ID: 2971673
[TBL] [Abstract][Full Text] [Related]
19. Protein C.
Esmon CT
Prog Hemost Thromb; 1984; 7():25-54. PubMed ID: 6099583
[TBL] [Abstract][Full Text] [Related]
20. The second laminin G-type domain of protein S is indispensable for expression of full cofactor activity in activated protein C-catalysed inactivation of factor Va and factor VIIIa.
Evenäs P; García de Frutos P; Nicolaes GA; Dahlbäck B
Thromb Haemost; 2000 Aug; 84(2):271-7. PubMed ID: 10959700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
